Marinus Pharmaceuticals Inc
NASDAQ:MRNS
Marinus Pharmaceuticals Inc
NASDAQ:MRNS
Price:
0.55
USD
Market Cap:
$30.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Marinus Pharmaceuticals Inc
NASDAQ:MRNS
|
US |
|
A
|
Allfunds Group PLC
AEX:ALLFG
|
UK |
|
V
|
Vishnu Prakash R Punglia Ltd
NSE:VPRPL
|
IN |
|
Bathurst Resources Ltd
ASX:BRL
|
NZ |
|
A
|
Aspen Pharmacare Holdings Ltd
JSE:APN
|
ZA |
|
C
|
Creditwest Faktoring AS
IST:CRDFA.E
|
TR |
|
Horizon Kinetics Holding Corp
OTC:HKHC
|
US |
|
G
|
Green Impact Partners Inc
XTSX:GIP
|
CA |
|
S
|
Southern Concrete Pile PCL
SET:SCP
|
TH |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MRNS's stock price target?
Not Available
MRNS doesn't have any price targets made by Wall Street professionals.
What is Marinus Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
36%
36%
The
compound annual growth rate
of Marinus Pharmaceuticals Inc's revenue for the next 4 years is
36%.
